Fact checked by Nick Blackmer It all started back in the spring of 2018 with a painful bump in my armpit. Confused, scared, ...

The use of combined oral contraceptives may delay the onset of hidradenitis suppurativa among women and may improve disease severity.

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

The following is a summary of “Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study,” published in the February ...

This case study explores a rare overlap of hidradenitis suppurativa and porokeratosis, as well as highlights the unique ...

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful lumps, abscesses, and scarring, primarily affecting areas where skin rubs together. Research in this ...

Living with a skin condition like hidradenitis suppurativa (HS) or folliculitis can be challenging, especially when you’re not sure what’s causing your symptoms. Both of these conditions cause ...

The following is a summary of “Development and External Validation of the Hidradenitis Suppurativa Cutaneous Abscess Prediction Score-2 (HSCAPS-2): A Clinical Decision Support Tool for Diagnosis of ...

Hidradenitis Suppurativa Market Outlook 2025-2035: The 7 major hidradenitis suppurativa market reached a value of USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 4.6 ...

Brensocatib is under clinical development by Insmed and currently in Phase I for Hidradenitis Suppurativa. According to GlobalData, Phase I drugs for Hidradenitis Suppurativa have a 91% phase ...

Opzelura is under clinical development by Incyte and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase II drugs for Hidradenitis Suppurativa have a 44% phase ...